pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
766
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
DA-1726
Obesity
$MTVA
MetaVia Inc.
0
catalysts
Phase 1
DAC-002
Small-Cell Lung Cancer
Hangzhou DAC Biotech Co Ltd
0
catalysts
Phase 1
DAY-301
Adenocarcinoma Of The Gastroesophageal Junction
$DAWN
Day One Biopharmaceuticals, Inc.
0
catalysts
Phase 1
← prev
page 8 of 26
next →
131
Pain
89
Neurology
1
DB-1317
Gastric Cancer
Duality Biotherapeutics Inc
0
catalysts
Phase 1
DCC-2812
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Deciphera Pharmaceuticals Inc
0
catalysts
Phase 1
DF-6002
Cervical Cancer
Dragonfly Therapeutics Inc
0
catalysts
Phase 1
DFP-11207
Gastric Cancer
Delta-Fly Pharma Inc
0
catalysts
Phase 1
DIACC-3010
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Evexta Bio SA
0
catalysts
Phase 1
DM-002
Solid Tumor
Doma Biopharmaceutical (Suzhou) Co Ltd
0
catalysts
Phase 1
DM-919
Solid Tumor
D2M Biotherapeutics Ltd
0
catalysts
Phase 1
DS-1103
Human Epidermal Growth Factor Receptor 2 Low Breast Cancer (HER2 Low Breast C…
Integral Molecular Inc
0
catalysts
Phase 1
DS-2243
Solid Tumor
Daiichi Sankyo Co Ltd
0
catalysts
Phase 1
DS-5361
Head And Neck Squamous Cell Carcinoma (HNSC)
Daiichi Sankyo Co Ltd
0
catalysts
Phase 1
DS-9051
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Daiichi Sankyo Co Ltd
0
catalysts
Phase 1
DSP-0038
Alzheimer's Disease
Sumitomo Pharma America Inc
0
catalysts
Phase 1
DSP-2342
Unspecified Psychiatric Disorders
Sumitomo Pharma America Inc
0
catalysts
Phase 1
DSP-3456
Treatment Resistant Depression
Sumitomo Pharma Co Ltd
0
catalysts
Phase 1
DST-2105
Keratoconjunctivitis Sicca (Dry Eye)
DelSiTech Ltd
0
catalysts
Phase 1
DVX-201
Myelodysplastic Syndrome (Preleukemia)
$COEP
Coeptis Therapeutics Holdings, Inc.
0
catalysts
Phase 1
DXDRGB-05
Coronavirus Disease 2019 (COVID-19)
Dx&Vx
0
catalysts
Phase 1
Deltacel
Non-Small Cell Lung Cancer
Immunocell Therapeutics Inc
0
catalysts
Phase 1
Dendocrin
Secondary Hyperparathyroidism
Novadiol Inc
0
catalysts
Phase 1
Diakine-DK210 (EGFR)
Bladder Cancer
Deka Biosciences Inc
0
catalysts
Phase 1
Drug for Unspecified Dermatological Disorders
Unspecified Dermatological Disorders
Neutrophil collagenase
Interstitial collagenase
TBT Pharma Inc
0
catalysts
Phase 1
E-1018
Malaria
Eisai Co Ltd
0
catalysts
Phase 1
E-2025
Alzheimer's Disease
Eisai Co Ltd
0
catalysts
Phase 1
E-2086
Type 1 Narcolepsy (Narcolepsy with Cataplexy)
Eisai Co Ltd
0
catalysts
Phase 1
E-2511
Alzheimer's Disease
Eisai Co Ltd
0
catalysts
Phase 1
E-7766
Solid Tumor
Eisai Co Ltd
0
catalysts
Phase 1
EB-105
Diabetic Macular Edema
Eluminex Biosciences Ltd
0
catalysts
